These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24958352)

  • 1. Glycosidase inhibitors: a patent review (2008-2013).
    Brás NF; Cerqueira NM; Ramos MJ; Fernandes PA
    Expert Opin Ther Pat; 2014 Aug; 24(8):857-74. PubMed ID: 24958352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective glycosidase inhibitors: A patent review (2012-present).
    Wadood A; Ghufran M; Khan A; Azam SS; Jelani M; Uddin R
    Int J Biol Macromol; 2018 May; 111():82-91. PubMed ID: 29305216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosidase inhibitors: update and perspectives on practical use.
    Asano N
    Glycobiology; 2003 Oct; 13(10):93R-104R. PubMed ID: 12851286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial approaches to iminosugars as glycosidase and glycosyltransferase inhibitors.
    Cipolla L; La Ferla B; Gregori M
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):571-82. PubMed ID: 17017877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From covalent glycosidase inhibitors to activity-based glycosidase probes.
    Willems LI; Jiang J; Li KY; Witte MD; Kallemeijn WW; Beenakker TJ; Schröder SP; Aerts JM; van der Marel GA; Codée JD; Overkleeft HS
    Chemistry; 2014 Aug; 20(35):10864-72. PubMed ID: 25100671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multivalent effect in glycosidase inhibition: a new, rapidly emerging topic in glycoscience.
    Compain P; Bodlenner A
    Chembiochem; 2014 Jun; 15(9):1239-51. PubMed ID: 24807298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in design and synthesis of bicyclic azasugars, carbasugars and related molecules as glycosidase inhibitors.
    Lahiri R; Ansari AA; Vankar YD
    Chem Soc Rev; 2013 Jun; 42(12):5102-18. PubMed ID: 23535828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iminosugars as therapeutic agents: recent advances and promising trends.
    Nash RJ; Kato A; Yu CY; Fleet GW
    Future Med Chem; 2011 Sep; 3(12):1513-21. PubMed ID: 21882944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugar-Derived Amidines and Congeners: Structures, Glycosidase Inhibition and Applications.
    Blériot Y; Auberger N; Désiré J
    Curr Med Chem; 2022; 29(7):1271-1292. PubMed ID: 34951354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosidase-targeting small molecules for biological and therapeutic applications.
    Kim Y; Li H; Choi J; Boo J; Jo H; Hyun JY; Shin I
    Chem Soc Rev; 2023 Oct; 52(20):7036-7070. PubMed ID: 37671645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect.
    Rísquez-Cuadro R; García Fernández JM; Nierengarten JF; Ortiz Mellet C
    Chemistry; 2013 Dec; 19(49):16791-803. PubMed ID: 24150869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of sugar-mimicking glycosidase inhibitors.
    Asano N; Kato A; Watson AA
    Mini Rev Med Chem; 2001 Jul; 1(2):145-54. PubMed ID: 12374106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nitric oxide synthase inhibitors: a patent review.
    Joubert J; Malan SF
    Expert Opin Ther Pat; 2011 Apr; 21(4):537-60. PubMed ID: 21338328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivalent Effect in Glycosidase Inhibition: The End of the Beginning.
    Compain P
    Chem Rec; 2020 Jan; 20(1):10-22. PubMed ID: 30993894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Feb; 24(2):201-16. PubMed ID: 24215328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analyses of the reaction coordinate of glycosidases.
    Davies GJ; Planas A; Rovira C
    Acc Chem Res; 2012 Feb; 45(2):308-16. PubMed ID: 21923088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Back to (non-)Basics: An Update on Neutral and Charge-Balanced Glycosidase Inhibitors.
    Simone MI; Mares LJ; Eveleens CA; McCluskey A; Pappin BB; Kiefel MJ; Houston TA
    Mini Rev Med Chem; 2018; 18(10):812-827. PubMed ID: 28969552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminopeptidase N (EC 3.4.11.2) inhibitors (2006 - 2010): a patent review.
    Su L; Fang H; Xu W
    Expert Opin Ther Pat; 2011 Aug; 21(8):1241-65. PubMed ID: 21619485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DMDP, L-homoDMDP and their C-3 fluorinated derivatives: synthesis and glycosidase-inhibition.
    Li YX; Huang MH; Yamashita Y; Kato A; Jia YM; Wang WB; Fleet GW; Nash RJ; Yu CY
    Org Biomol Chem; 2011 May; 9(9):3405-14. PubMed ID: 21423946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.